Illustrative scenario

Deliver Variant Reports in 5 Days Instead of 21 with Automated Genomics Pipelines

For the Head of Bioinformatics at a clinical genomics lab, the distance between receiving a sample and delivering an actionable variant report is measured in pipeline execution time, annotation queue depth, and the backlog of variants of uncertain significance waiting for clinical scientist review. When annual MSA value runs $400K to $1.5M and turnaround is a key differentiator with ordering physicians and health system clients, pipeline velocity is a revenue variable, not just an operational one.

Up and running in ~16 wkFor: Head of Bioinformatics, clinical genomics lab
Estimate your payback
~4 mo
Payback period
$825K
Est. savings / year
+$525K
Year-1 net

Rough estimate — change the numbers to match your business. We scope the real figures with you on a call.

Where Clinical Genomics Pipelines Create Friction

Building and maintaining WGS variant-calling pipelines that follow GATK Best Practices is technically demanding — the workflow spans FASTQ preprocessing, variant calling, joint genotyping, and annotation against reference databases including gnomAD and ClinVar. When pipelines are built and maintained manually, each new sample type or sequencer update requires engineering time. More critically, the annotation and triage step — separating clinically relevant variants from variants of uncertain significance — often creates a queue that stretches turnaround time to three weeks or more, compressing clinical utility for the ordering provider.

How an AI Agent Builds and Runs the Pipeline

An AI Labor Company agent mines bioinformatics pipeline design review emails and GATK Best Practices documentation review threads to deploy an agent that builds Nextflow WGS variant-calling pipelines tailored to your lab's sample types and sequencing infrastructure. The agent annotates VCFs against gnomAD and ClinVar automatically, then routes only variants of uncertain significance to clinical scientists for interpretation — every case where the annotation is definitive flows through without manual intervention. Labs running this workflow typically go live in approximately 16 weeks.

Speed as a Revenue Driver

Cutting variant report turnaround from 21 days to 5 is not primarily a cost story — it is a capacity and competitive positioning story. A lab delivering 5-day results can serve more concurrent ordering relationships, take on higher-volume health system contracts, and differentiate on turnaround in a market where competing labs offer similar technical capabilities. The 45–65% reduction in manual pipeline and annotation effort means the same bioinformatics team handles a substantially larger sample throughput — which is the mechanism by which revenue grows without a proportional increase in headcount.

Questions

Does the agent support both WGS and WES, or only whole-genome sequencing?

The initial pipeline build focuses on WGS, which typically drives the highest per-sample complexity. Whole-exome sequencing (WES) workflows can be added in a subsequent phase, and the annotation logic against gnomAD and ClinVar applies to both.

How does the agent handle GATK Best Practices updates and new gnomAD releases?

AI Labor Company maintains the pipeline tooling layer and coordinates updates when GATK releases new Best Practices recommendations or gnomAD publishes a new database version. Your team is notified before any annotation reference update is applied to production runs.

Related use cases

Illustrative scenario for data, research & analytics. Figures are example ranges, not guarantees — we scope real numbers with you on a call.

Want this running in your business?

We'll scope an agent for this on a free 15-minute call.

Book a free call